UltraSPECT, based in Haifa, Israel, with U.S. offices in Auburndale, MA, is a leading supplier of Software Products for the Nuclear Medicine imaging practices providing innovative and cost-effective solutions for improved clinical outcomes and patient safety delivered by Gamma Cameras and PET.
Based on proprietary, innovative reconstruction algorithms technology, Wide-Beam Reconstruction (WBRTM), the Company's imaging solutions to lower radiopharmaceutical doses, shorten acquisition times, and increase image resolution. UltraSPECT products include the Xpress.CardiacTM, the Xpress3.CardiacTM, and the Xpress/Xact.BoneTM.
Lower radiopharmaceutical doses reduce patient exposure to radiation. Shorter acquisitions improve patient comfort, reduce patient motion, and increase patient throughput. Higher resolution offers improved lesion localization, raising diagnostic confidence.
Compatible with most major manufacturers' cameras and workstations, these products can be installed in a couple of days and offer a virtually transparent interface between the gamma camera and workstation, requiring little or no technologist involvement.
UltraSPECT products are FDA cleared for distribution in the U.S. market and are legally marketed in Europe under the CE mark. The Wide-Beam Reconstruction applications have been tested in leading hospitals and clinics and are already in routine use in hundreds of NM imaging centers in the U.S., Europe, Asia and Australia.
Current R&D activities are focused on more advanced solutions, taking Molecular Imaging into new realms of performance.